Le Cacheux P, Hurault de Ligny B, Reman O, Ryckelynck J P
Service de néphrologie, Chru Caen.
Rev Med Interne. 1990 May-Jun;11(3):250-1.
The authors report a case of non fatal visceral leishmaniasis in a renal transplant recipient and underline the fact that immunosuppressive treatments facilitate the occurrence of this disease. In patients with fever, pancytopenia and spleen enlargement, it is capital to inquire whether they have sojourned in a country where leishmaniasis is endemic. The diagnosis is then confirmed by bone marrow examination. Treatment rests on antimony derivatives, but these must be handled with caution in immunocompromised patients.
作者报告了一例肾移植受者发生的非致命性内脏利什曼病病例，并强调免疫抑制治疗会促使该病的发生这一事实。对于发热、全血细胞减少和脾脏肿大的患者，询问他们是否曾旅居利什曼病流行的国家至关重要。然后通过骨髓检查确诊。治疗依赖于锑剂衍生物，但在免疫功能低下的患者中使用时必须谨慎。
